Company · CIK 0001801170 · SIC 6324 — Hospital & Medical Service Plans · Nasdaq
CLOVER HEALTH INVESTMENTS, CORP. /DE · CLOV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 18, 4:22 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 1,921 | $4.56 | $8,760 | 2,803,446 | −0.07% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 17, 5:29 pm EDT | Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLER | 3,170 | $4.64 | $14,709 | 275,897 | −1.14% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:27 pm EDT | Conrad WaiCEO, Counterpart Health | 300,000 | $4.72 | $1,416,000 | 1,170,056 | −20.4% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 8:11 pm EDT | Karen SoaresChief Legal Officer | 6,846 | $4.78 | $32,724 | 1,607,371 | −0.42% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:48 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 9,273 | $4.78 | $44,325 | 2,805,367 | −0.33% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 14, 8:52 pm EDT | Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLER | 20,000 | $5.16 | $103,200 | 279,067 | −6.69% | |
| Aug 17, 2026 SForm 4 → | Aug 17, 5:58 pm EDT | Joseph Clay ThorntonInterim CFO | 17,775 | $4.39 | $78,032 | 1,249,526 | −1.40% | 10b5-1 |
| Aug 12, 2026 AForm 4 → | Aug 13, 4:23 pm EDT | Karen SoaresChief Legal Officer | 108,695 | — | — | 1,614,217 | — | |
| Aug 12, 2026 AForm 4 → | Aug 13, 4:20 pm EDT | Joseph Clay ThorntonInterim CFO | 54,347 | — | — | 1,267,301 | — | |
| Aug 10, 2026 SForm 4 → | Aug 10, 6:30 pm EDT | Andrew ToyChief Executive Officer, Director | 87,798 | $4.65 | $408,261 | 9,459,316 | −0.92% | 10b5-1 |
| Jul 20, 2026 SForm 4 → | Jul 20, 5:48 pm EDT | Karen SoaresChief Legal Officer | 51,700 | $4.51 | $233,167 | 1,505,522 | −3.32% | 10b5-1 |
| Jul 17, 2026 SForm 4 → | Jul 17, 5:26 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 4,839 | $4.53 | $21,921 | 2,814,640 | −0.17% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:59 pm EDT | Andrew ToyChief Executive Officer, Director | 62,711 | $4.67 | $292,860 | 9,547,114 | −0.65% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:55 pm EDT | Conrad WaiCEO, Counterpart Health | 24,215 | $4.67 | $113,084 | 1,145,699 | −2.07% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:50 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 13,119 | $4.67 | $61,266 | 2,819,479 | −0.46% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:44 pm EDT | Karen SoaresChief Legal Officer | 10,519 | $4.67 | $49,124 | 1,557,222 | −0.67% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:42 pm EDT | Joseph Clay ThorntonInterim CFO | 4,630 | $4.67 | $21,622 | 1,212,954 | −0.38% | 10b5-1 |
| Jul 8, 2026 SForm 4 → | Jul 9, 4:45 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 2,384 | $4.68 | $11,157 | 2,832,598 | −0.08% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 6, 5:57 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 6,229 | $5.26 | $32,765 | 2,834,982 | −0.22% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 1, 6:33 pm EDT | Andrew ToyChief Executive Officer, Director | 313,476 | $5.32 | $1,667,692 | 9,609,825 | −3.16% | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 18, 6:42 am EDT | Jamie L. ReynosoCEO, Medicare Advantage | 2,360 | $4.78 | $11,281 | 2,841,211 | −0.08% | 10b5-1 |
| Jun 16, 2026 SForm 4 → | Jun 17, 8:13 am EDT | Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLER | 12,102 | $4.86 | $58,816 | 299,067 | −3.89% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 16, 8:16 am EDT | Karen SoaresChief Legal Officer | 4,681 | $4.61 | $21,579 | 1,567,741 | −0.30% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 16, 8:14 am EDT | Jamie L. ReynosoCEO, Medicare Advantage | 6,350 | $4.61 | $29,274 | 2,843,571 | −0.22% | 10b5-1 |
| Jun 11, 2026 SForm 4 → | Jun 11, 5:28 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 7,289 | $4.91 | $35,789 | 2,849,921 | −0.26% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.